(Forbes) – It used to be that the major hurdle in getting a new drug approved was successfully completing phase 3 trials – the long-term...
(Forbes) – It used to be that the major hurdle in getting a new drug approved was successfully completing phase 3 trials – the long-term...
(USA Today) – The U.S. Food and Drug Administration on Wednesday approved Amgen Inc.’s heart-failure treatment Corlanor, which had been designated for priority review in August. The...